Introduction
cancer death, Pancreatic cancer, death
PANCREATIC CANCER, POSTOPERATIVE COMPLICATIONS, INFLAMMATORY RESPONSE
Pancreatic cancer is currently the seventh leading cause of cancer death worldwide and the third leading cause of cancer-related death in the USA [Dexmedetomidine (DEX) is a highly selective As a result of the potential immunomodulation of DEX, we hypothesized that the use of DEX could attenuate the inflammatory response induced by LPD. In parallel, we also investigated the incidence of postoperative complications related.